These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32489345)

  • 21. [Mexican consensus on the diagnosis and treatment of atopic dermatitis in adolescents and adults].
    Rincón-Pérez C; Larenas-Linnemann D; Figueroa-Morales MA; Luna-Pech J; García-Hidalgo L; Macías-Weinmann A; Gómez-Vera J; Barba-Gómez JF; Matta-Campos JJ; Guevara-Sangines E; Jurado-Santacruz F; López Tello-Santillán A; Ortega-Martell JA; Pulido-Díaz N; Serrano-Jaén LG; Toledo-Bahena M; Villanueva-Quintero G; Mayorga-Butrón JL
    Rev Alerg Mex; 2018; 65 Suppl 2():s8-s88. PubMed ID: 30278478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Japanese guidelines for atopic dermatitis 2017.
    Katayama I; Aihara M; Ohya Y; Saeki H; Shimojo N; Shoji S; Taniguchi M; Yamada H;
    Allergol Int; 2017 Apr; 66(2):230-247. PubMed ID: 28209325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent Advances in Pharmacotherapeutic Paradigm of Mild to Recalcitrant Atopic Dermatitis.
    Hussain Z; Sahudin S; Thu HE; Shuid AN; Bukhari SN; Kumolosasi E
    Crit Rev Ther Drug Carrier Syst; 2016; 33(3):213-263. PubMed ID: 27910751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biologic Treatment Options for Pediatric Psoriasis and Atopic Dermatitis.
    Cline A; Bartos GJ; Strowd LC; Feldman SR
    Children (Basel); 2019 Sep; 6(9):. PubMed ID: 31514420
    [No Abstract]   [Full Text] [Related]  

  • 25. Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A serie of cases.
    García M; Durán-Crane A; Chapman E; García E
    Rev Alerg Mex; 2019; 66(3):282-291. PubMed ID: 31606011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dupilumab for Atopic Dermatitis: The Silver Bullet We Have Been Searching for?
    Tameez Ud Din A; Malik I; Arshad D; Tameez Ud Din A
    Cureus; 2020 Apr; 12(4):e7565. PubMed ID: 32382467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [TWO CASES OF USING DUPILUMAB FOR REFRACTORY ATOPIC DERMATITIS WHO HAD HISTORIES OF BACTEREMIA AND UNDERLYING CONGENITAL HEART DISEASE].
    Hamada K; Kasai K; Sasaki Y
    Arerugi; 2019; 68(6):701-706. PubMed ID: 31308337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis.
    Ivert LU; Wahlgren CF; Ivert L; Lundqvist M; Bradley M
    Acta Derm Venereol; 2019 Apr; 99(4):375-378. PubMed ID: 30653240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [What additional measures should be recommended in atopic dermatitis in children?].
    Boralevi F
    Ann Dermatol Venereol; 2005 Jan; 132 Spec No 1():1S79-85. PubMed ID: 15984298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics and prescription patterns of traditional Chinese medicine in atopic dermatitis patients: ten-year experiences at a medical center in Taiwan.
    Lin JF; Liu PH; Huang TP; Lien AS; Ou LS; Yu CH; Yang SL; Chang HH; Yen HR
    Complement Ther Med; 2014 Feb; 22(1):141-7. PubMed ID: 24559829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial.
    Blauvelt A; de Bruin-Weller M; Gooderham M; Cather JC; Weisman J; Pariser D; Simpson EL; Papp KA; Hong HC; Rubel D; Foley P; Prens E; Griffiths CEM; Etoh T; Pinto PH; Pujol RM; Szepietowski JC; Ettler K; Kemény L; Zhu X; Akinlade B; Hultsch T; Mastey V; Gadkari A; Eckert L; Amin N; Graham NMH; Pirozzi G; Stahl N; Yancopoulos GD; Shumel B
    Lancet; 2017 Jun; 389(10086):2287-2303. PubMed ID: 28478972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current novel approaches in systemic therapy of atopic dermatitis: specific inhibition of cutaneous Th2 polarized inflammation and itch.
    Werfel T; Biedermann T
    Curr Opin Allergy Clin Immunol; 2015 Oct; 15(5):446-52. PubMed ID: 26308331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dupilumab: A review of its use in the treatment of atopic dermatitis.
    Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dupilumab treatment improves quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a randomized, placebo-controlled clinical trial.
    Tsianakas A; Luger TA; Radin A
    Br J Dermatol; 2018 Feb; 178(2):406-414. PubMed ID: 28845523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on Atopic Dermatitis.
    Torres T; Ferreira EO; Gonçalo M; Mendes-Bastos P; Selores M; Filipe P
    Acta Med Port; 2019 Sep; 32(9):606-613. PubMed ID: 31493365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic Treatment for Severe Atopic Dermatitis.
    Giavina-Bianchi M; Giavina-Bianchi P
    Arch Immunol Ther Exp (Warsz); 2019 Apr; 67(2):69-78. PubMed ID: 30159581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic, prophylactic and therapeutic guidelines in patients with atopic dermatitis. Position paper by the task force of the National Specialists on Dermatology, Venereology and Allergology].
    Gliński W; Kruszewski J; Silny W; Kurzawa R; Czarnecka-Operacz M; Baran E; Szepietowski J;
    Pol Merkur Lekarski; 2004; 17 Suppl 3():3-15. PubMed ID: 15688665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part I. Evaluation of clinical score].
    Silny W; Czarnecka-Operacz M; Silny P
    Wiad Lek; 2005; 58(1-2):47-55. PubMed ID: 15991553
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
    Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
    J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Oral therapy for atopic dermatitis in year 2000. Questionnaire Study to Boarding Members of Japanese Society for Allergology].
    Aoki T; Kono T
    Arerugi; 2003 Apr; 52(4):434-43. PubMed ID: 12754420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.